drugdeliverybusiness12h
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
Insulin Pump Market To Surge From $6.10 Billion In 2024 To $25.40 Billion By 2033 At 17.2% CAGR Astute Analytica
CHICAGO, NY, UNITED STATES, January 17, 2025 /EINPresswire / -- The global insulin pump <a target=_blank href= ...